| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Fr | Eason Technology receives NYSE notification for late filing | ||
| Fr | Eason Technology to acquire Chinese property for $3.5 million | ||
| Fr | Jefferies resumes AO Smith stock coverage with Hold rating, $75 target | ||
| Fr | Haydale directors acquire shares, options following SMCC acquisition | ||
| Fr | Woodbois delisted after audit delays amid legacy management failures | ||
| Fr | Boyd Group completes acquisition of Joe Hudson's Collision Center | ||
| Fr | Goldman Sachs maintains Neutral rating on Oklo stock amid Meta deal | ||
| Fr | Ekinops appoints Lionel Chmilewsky as new CEO effective January 12 | ||
| Fr | Propifi Bonds completes December interest payments across note series | ||
| Fr | EKF Diagnostics buys back 200,000 shares at average price of 25.989p | ||
| Fr | Mirum Pharmaceuticals begins Phase 2 trial for Fragile X syndrome drug | ||
| Fr | Bright Minds Biosciences closes $175 million public offering | ||
| Fr | AIIB launches $1bn bond offering with 4.125% coupon | ||
| Fr | Spreadex LTD reduces stake in Altona Rare Earths to 4.69% | ||
| Fr | CN sets new records for grain movement in December and 2025 | ||
| Fr | Cemtrex secures $4 million through share offering | ||
| Fr | Liquidia stock holds steady as BTIG reiterates Buy rating on strong Yutrepia sales | ||
| Fr | Guardian Metal Resources finance director purchases shares | ||
| Fr | CQS New City High Yield Fund to issue 1.25 million new shares | ||
| Fr | KeifeRx and Amneal partner on Parkinson's disease drug development | ||
| Fr | Elliott and Morning Calm complete acquisition of City Office REIT | ||
| Fr | Phoenix shareholders approve re-domicile from UK to Gibraltar | ||
| Fr | FMR LLC increases stake in Hiscox to 7.88% of voting rights | ||
| Fr | ValiRx signs evaluation agreement with McGill and IRICoR | ||
| Fr | SEED Innovations chair increases stake with 1.19 million share purchase |